| AXSOME THERAPEUT. DL-0001 |
| USA |
| Gesundheit |
| US05464T1043 / A2AA7B |
| 19X (Frankfurt) / AXSM (NASDAQ) |
| FRA:19X, ETR:19X, 19X:GR, NASDAQ:AXSM |
| - |
| https://axsome.com/ |
|
Axsome Therapeutics is a commercial-stage biopharmaceutical company specializing in the development and commercialization of small-molecule medicines and novel therapies targeting central nervous system disorders. The company focuses on conditions wi..
>Volltext.. |
| 11206.12 Mio. EUR |
| 11132.08 Mio. EUR |
| 622.27 Mio. EUR |
| -147.04 Mio. EUR |
| -165.45 Mio. EUR |
| -3.29 EUR |
| 193.21 Mio. EUR |
| 268.07 Mio. EUR |
| -62.14 Mio. EUR |
| 0.69 |
| 53.46% |
| 36.64% |
| - |
| - |
| - |
| 5 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 21.436.278 Euro. |
| AXSOME |
| 24.06.26 |
|
||||
|
||||
|
||||
|